| Opens October 16 |
Welcome and Orientation; Share Your Stories and Results |
Dr. Ruth Berg, Project Director, PSP-One Project |
| |
Why the Private Sector Matters: Evidence from the Field |
Dr Ruth Levine, director of Programs and Senior Fellow, Center for Global Development |
Part 1: Strengths and Limitations of Private Sector Strategies |
| Opens November 13 |
Can Generic Contraceptive Manufacturers Increase Equity without Compromising Quality? |
Ms. Francoise Armand, Director of Social Marketing and Pharmaceutical Partnerships, PSP-One Project |
| |
The Impact of Private Clinic Networks on Client Service Access and Quality: Evidence from Ethiopia, India, and Pakistan |
Dr. Amy Tsui, Director , Bill and Melinda Gates Institute for Population and Reproductive Health, Johns Hopkins Bloomberg School of Public Health |
| |
Insurance As A Means to Improve Access to Care: A Silver-Plated Bullet? |
Dr. Tania Dmytraczenko, Senior Health Economist, PSP-One Project |
| |
Discussion Area: Provide your comments/questions and receive answers directly from the presenters |
November 14 7:00am to 9:00am EST |
Live Facilitated Discussion: Meet experts, colleagues, friends to discuss why the private sector matters in health. This session is facilitated by a private sector health professional.
|
Part 2: Public/Private Interface |
| Opens November 15 |
Achieving Twin Objectives of Equity and Quality: Contracting Health Services with the Private Sector |
Dr. Benjamin Loevinsohn, Lead Public health Specialist, SASHD, World Bank |
| |
Vouchers: Increasing Access and Quality through Consumer Choice |
Dr. Claus-Peter Janisch, Senior Medical Advisor, KfW |
| |
The (In) Visible Hand of Government in the Medical Marketplace |
Mr. Rich Feeley, Boston University Center for International Health and Development |
| |
Discussion Area: Provide your comments/questions and receive answers directly from the presenters |
November 16 10:00am to 12:00pm EST |
Live Facilitated Discussion: Meet experts, colleagues, friends to discuss why the private sector matters in health. This session is facilitated by a private sector health professional.
|
Part 3: Perspectives on the Private Sector: A Discussion With Leading Health Organizations |
| Opens November 17 |
- Mr. Richard Greene, Director, Office of Health, Infectious Disease and Nutrition, Bureau of Global Health, USAID
- Dr. Claus-Peter Janisch, Senior Medical Advisor, KfW
- Dr. Alexander Preker, Lead Health Economist, Health, Nutrition, and Population, World Bank
- Dr. James D. Shelton, Senior Medical Scientist, Office of population and Reproductive Health, Bureau of Global Health, USAID
- Dr. Phylida Travis, Health Systems Advisor, World Health Organization
|
| |
Discussion Area: Provide your comments/questions and receive answers directly from the presenters |
| 1:00pm to 3:00pm EST |
Live Facilitated Discussion: Meet experts, colleagues, friends to discuss why the private sector matters in health. This session is facilitated by a private sector health professional.
|
| |
Summarizing Remarks and Live Questions/Answers/Comments |
Dr. Ruth Berg. Project Director. PSP-One Project |